Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

The guidelines for the diagnosis, surveillance and therapy of Barrett’s esophagus were originally published by the American College of Gastroenterology in 1998 and updated in 2002. These and other guidelines undergo periodic review. Significant advances have occurred in the area of Barrett’s esophagus over the past four years leading to another revision of the prior guidelines. These advances include the potential use of esophageal capsule endoscopy for the diagnosis and screening of Barrett’s esophagus, data regarding the outcome of low-grade dysplasia, the treatment of high-grade dysplasia using photodynamic therapy, and the development of new ablation techniques such as radiofrequency ablation. These guidelines are intended to be applied by physicians who see Barrett’s esophagus patients and are intended to indicate a preferred, but certainly not the only, acceptable approach. Physicians need to choose the course best suited to the individual patient and to the variables that exist at the time of decision making. The guidelines are for adult patients with the diagnosis of Barrett’s esophagus, as defined herein. Both these and the original guidelines were developed under auspices of the American College of Gastroenterology and the Practice Parameters Committee and approved by the Board of Trustees. The world literature was reviewed extensively for the original guidelines and once again reviewed using the National Library of Medicine database. Search terms used included Barrett’s esophagus, esophageal neoplasm, esophagus, intestinal metaplasia, esophageal diseases, and adenocarcinoma, all appropriate studies and any additional ones found in reference to these papers were obtained and reviewed. Evidence was available from a hierarchy of trials and randomized controlled trials were given the greatest weight. Abstracts presented at national and international meetings were only used when unique data from ongoing trials were presented. When scientific data were lacking, recommendations are based on expert opinion. The recommendations made are based on the level of evidence found. Grade A recommendations imply that there is consistent level 1 evidence (randomized controlled trials), Grade B indicates that the evidence would be level 2 or 3 which are cohort studies or case control studies. Grade C recommendations are based on level 4 studies meaning case series or poor quality cohort studies, and Grade D recommendations are based on level 5 evidence meaning expert opinion.

[1]  M. Savary,et al.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. , 1975, The Journal of thoracic and cardiovascular surgery.

[2]  F. Ellis,et al.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. , 1978, American journal of clinical pathology.

[3]  R. Riddell Dysplasia in inflammatory bowel disease. , 1980, Clinics in gastroenterology.

[4]  D. Skinner,et al.  Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. , 1983, Archives of surgery.

[5]  D. Skinner,et al.  Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.

[6]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[7]  J. Boitnott,et al.  The spectrum of carcinoma arising in Barrett's esophagus: A clinicopathologic study of 26 patients , 1984, The American journal of surgical pathology.

[8]  J. Rosenberg,et al.  Analysis of adenocarcinoma in barrett's esophagus utilizing a staging system , 1985, Cancer.

[9]  S. Spechler,et al.  Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. , 1986, Gastroenterology.

[10]  B. Reid,et al.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.

[11]  R. Jensen,et al.  Famotidine: effective treatment of Zollinger-Ellison syndrome. , 1987, Journal of clinical gastroenterology.

[12]  W. Macdonald,et al.  Adenocarcinoma of the Esophagus and/or Gastric Cardia , 1987, Cancer.

[13]  C. Winters,et al.  In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. , 1987, Gastrointestinal endoscopy.

[14]  S. McClave,et al.  Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. , 1987, Gastrointestinal endoscopy.

[15]  C. Winters,et al.  Esophageal acid sensitivity in Barrett's esophagus. , 1987, Journal of clinical gastroenterology.

[16]  D. Grueneberg,et al.  DNA content in Barrett's esophagus and esophageal malignancy. , 1987, The American journal of gastroenterology.

[17]  R. Sampliner,et al.  Ornithine decarboxylase activity in Barrett's esophagus: a potential marker for dysplasia. , 1988, Gastroenterology.

[18]  R. R. Smith,et al.  Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. , 1988, Human pathology.

[19]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[20]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[21]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[22]  R. Hunt,et al.  A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus. , 1989, Gastrointestinal endoscopy.

[23]  R. Sampliner,et al.  Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. , 1989, Gastroenterology.

[24]  Richard L. Abbott,et al.  A Follow-up Study , 1990 .

[25]  D J Ballard,et al.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. , 1990, Gastroenterology.

[26]  A. Zinsmeister,et al.  Prevalence of columnar-lined (Barrett's) esophagus , 1990 .

[27]  N. Walker,et al.  Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. , 1991, Gut.

[28]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[29]  B. Reid,et al.  Endoscopic biopsy technique for acquiring larger mucosal samples. , 1991, Gastrointestinal endoscopy.

[30]  P. Blount,et al.  Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. , 1992, Gastroenterology.

[31]  S. Spechler Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. , 1992, The New England journal of medicine.

[32]  D. Hopwood,et al.  Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. , 1992, Scandinavian journal of gastroenterology.

[33]  P. Blount,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.

[34]  D. Lane,et al.  Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. , 1992, Gastroenterology.

[35]  Patricia L. Blount,et al.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.

[36]  A R Zinsmeister,et al.  Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. , 1993, Gastroenterology.

[37]  W. Samowitz,et al.  Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. , 1993, Gastroenterology.

[38]  T. Demeester,et al.  Functional foregut abnormalities in Barrett's esophagus. , 1993, The Journal of thoracic and cardiovascular surgery.

[39]  F. Ellis,et al.  Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.

[40]  R. Lebovitz,et al.  p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.

[41]  D. Katzka,et al.  Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. , 1994, The American journal of gastroenterology.

[42]  C. Lightdale,et al.  Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. , 1994, Gastrointestinal endoscopy.

[43]  J. Peters,et al.  Is Barrett's metaplasia the source of adenocarcinomas of the cardia? , 1994, Archives of surgery.

[44]  Carissa A. Sanchez,et al.  p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. , 1994, Gastroenterology.

[45]  T. Hennessy,et al.  Proliferating cell nuclear antigen in the assessment of Barrett's mucosa , 1994, The British journal of surgery.

[46]  P. Stevens,et al.  Hypertensive emergency and ventricular tachycardia after endoscopic epinephrine injection of a Mallory-Weiss tear. , 1994, Gastrointestinal endoscopy.

[47]  R. Goyal,et al.  Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.

[48]  J. Peters,et al.  Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.

[49]  S. Steinberg,et al.  Expansion of the Ki‐67 proliferative compartment correlates with degree of Dysplasia in Barrett's esophagus , 1995, Cancer.

[50]  Treatment of Barrett's metaplasia by antireflux surgery and endoscopic laser ablation: Clinical experience in ten patients , 1995 .

[51]  G. Meyer,et al.  Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease , 1995 .

[52]  J. Pignon,et al.  Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. , 1995, The American journal of surgical pathology.

[53]  J. Freston,et al.  Critical issues in the management of gastroesophageal reflux disease. , 1995, European journal of gastroenterology & hepatology.

[54]  D. Castell,et al.  Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. , 1995, Archives of internal medicine.

[55]  J. Jankowski,et al.  Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables , 1995, International journal of cancer.

[56]  A. Cameron,et al.  Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. , 1995, Gastroenterology.

[57]  M. Johnston,et al.  The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. , 1996, The American journal of gastroenterology.

[58]  R. Sampliner,et al.  Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. , 1996, Gastrointestinal endoscopy.

[59]  M. Sivak,et al.  Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. , 1996, Gastrointestinal endoscopy.

[60]  R. Heitmiller,et al.  Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.

[61]  L. Laine,et al.  Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. , 1996, Gastrointestinal endoscopy.

[62]  J. Richardson,et al.  The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. , 1996, Annals of surgery.

[63]  G. Lapertosa,et al.  Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. , 1996, Gastrointestinal endoscopy.

[64]  B. Overholt,et al.  Photodynamic therapy for Barrett's esophagus: clinical update. , 1996, The American journal of gastroenterology.

[65]  R. Cherian,et al.  Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. , 1996, The American journal of gastroenterology.

[66]  Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1996 .

[67]  J. Richter,et al.  Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. , 1996, Gastroenterology.

[68]  A. Bhattacharyya,et al.  Intestinal metaplasia of the gastric cardia. , 1997, The American journal of gastroenterology.

[69]  A. Bhattacharyya,et al.  Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. , 1997, The American journal of gastroenterology.

[70]  S. Re,et al.  The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997 .

[71]  P. Schneider,et al.  Early adenocarcinoma in Barrett's oesophagus , 1997, The British journal of surgery.

[72]  R. Sandler,et al.  The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.

[73]  Temporary left external axillofemoral bypass during repair of a leaking type B aortic dissection , 1997, The British journal of surgery.

[74]  H. Garewal,et al.  Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium. , 1997, The American journal of gastroenterology.

[75]  M. Helfand,et al.  Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.

[76]  R. Sampliner,et al.  Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. , 1997, The American journal of gastroenterology.

[77]  S. Merigliano,et al.  Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). , 1997, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[78]  M. Gammon,et al.  Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[79]  A. Cameron Management of Barrett's esophagus. , 1998, Mayo Clinic proceedings.

[80]  P. Aló,et al.  DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. , 1998, Cytometry.

[81]  Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus , 1998 .

[82]  G. Tytgat,et al.  Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.

[83]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[84]  N. Dubin,et al.  Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[85]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[86]  S. Meltzer,et al.  Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1 , 2006 .

[87]  J. Byrne,et al.  Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation , 1998, American Journal of Gastroenterology.

[88]  J. Hunter,et al.  Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus. , 1999, American journal of surgery.

[89]  R. Fitzgerald,et al.  Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. , 1999, Gastroenterology.

[90]  N. Powe,et al.  Management of Barrett's esophagus: a national study of practice patterns and their cost implications , 1999, American Journal of Gastroenterology.

[91]  K. Schrör,et al.  Cyclooxygenase-2 expression in human esophageal carcinoma. , 1999, Cancer research.

[92]  N. Talley,et al.  Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. , 1999, Gastrointestinal endoscopy.

[93]  C. Begg,et al.  impact of Hospital Volume on Operative Mortality for Major Cancer Surgery , 1999 .

[94]  D. Castell,et al.  Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease , 1999, American Journal of Gastroenterology.

[95]  E. Kuipers,et al.  Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study , 1999, Gut.

[96]  J H Peters,et al.  Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. , 1999, Annals of surgery.

[97]  Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma , 1999 .

[98]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[99]  U. Ladabaum,et al.  Barrett's Esophagus with High-Grade Dysplasia , 1999 .

[100]  R. Wong,et al.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. , 1999, Gastroenterology.

[101]  The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999 .

[102]  N. Powe,et al.  Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[103]  Patricia L. Blount,et al.  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[104]  J. Goldblum,et al.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression , 2000, American Journal of Gastroenterology.

[105]  G. Falk,et al.  Practice patterns for surveillance of Barrett's esophagus in the united states. , 2000, Gastrointestinal endoscopy.

[106]  P. Schauer,et al.  Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. , 2000, Surgery.

[107]  L. Bonavina,et al.  Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus , 2002, Surgical Endoscopy And Other Interventional Techniques.

[108]  Patricia L. Blount,et al.  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables , 2001, American Journal of Gastroenterology.

[109]  J. Peters,et al.  Long-Term Outcome of Antireflux Surgery in Patients With Barrett’s Esophagus , 2001, Annals of surgery.

[110]  M. Feith,et al.  Preoperative chemotherapy unmasks underlying Barrett’s mucosa in patients with adenocarcinoma of the distal esophagus , 2002, Surgical Endoscopy.

[111]  M. Guelrud,et al.  Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[112]  Robert Edson,et al.  Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux , 2001, American Journal of Gastroenterology.

[113]  Dennis M. Riehle,et al.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. , 2001, Gastroenterology.

[114]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[115]  K. Badizadegan,et al.  Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. , 2001, Gastroenterology.

[116]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[117]  Carissa A. Sanchez,et al.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression , 2001, American Journal of Gastroenterology.

[118]  Noel S Weiss,et al.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.

[119]  J. Peters,et al.  Vagal-Sparing Esophagectomy: A More Physiologic Alternative , 2002, Annals of surgery.

[120]  G. Lapertosa,et al.  Risk factors for Barrett's esophagus: A case‐control study , 2002, International journal of cancer.

[121]  L. Brown,et al.  Epidemiologic trends in esophageal and gastric cancer in the United States. , 2002, Surgical oncology clinics of North America.

[122]  Kenneth K Wang,et al.  Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.

[123]  M. Ferguson,et al.  Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients , 2002, Journal of Gastrointestinal Surgery.

[124]  H. El‐Serag,et al.  Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? , 2003, American Journal of Gastroenterology.

[125]  K. Ragunath,et al.  A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. , 2003, Endoscopy.

[126]  G. Cooper Endoscopic screening and surveillance for Barrett's esophagus: can claims data determine its effectiveness? , 2003, Gastrointestinal endoscopy.

[127]  R. Sampliner,et al.  Endoscopic Surveillance of Columnar-Lined Esophagus: Frequency of Intestinal Metaplasia Detection and Impact of Antireflux Surgery , 2003, American Journal of Gastroenterology.

[128]  K. Kerlikowske,et al.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.

[129]  A. Bhattacharyya,et al.  Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus , 2004, American Journal of Gastroenterology.

[130]  E. Steyerberg,et al.  5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial , 2004, Gut.

[131]  R. Cherian,et al.  Prospective Evaluation of Intestinal Metaplasia and Dysplasia Within the Cardia of Patients with Barrett's Esophagus , 1997, Digestive Diseases and Sciences.

[132]  J. Goldblum,et al.  Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study. , 2004, Gastrointestinal endoscopy.

[133]  J. Hunter,et al.  Significance of Intestinal Metaplasia in Different Areas of Esophagus Including Esophagogastric Junction , 1997, Digestive Diseases and Sciences.

[134]  Janusz Jankowski,et al.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.

[135]  H. Sue-Ling,et al.  Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer , 2004, The British journal of surgery.

[136]  S. DeMeester,et al.  Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. , 2004, The Annals of thoracic surgery.

[137]  M. Mayo,et al.  Yield of Intestinal Metaplasia in Patients with Suspected Short-Segment Barrett's Esophagus (SSBE) on Repeat Endoscopy , 2002, Digestive Diseases and Sciences.

[138]  Carissa A. Sanchez,et al.  Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. , 2005, The Lancet. Oncology.

[139]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[140]  N. Shaheen,et al.  Effect of a New Diagnosis of Barrett's Esophagus on Insurance Status , 2005, The American Journal of Gastroenterology.

[141]  H. El‐Serag,et al.  Abdominal Obesity and the Risk of Barrett's Esophagus , 2005, The American Journal of Gastroenterology.

[142]  W. Hop,et al.  The Incidence of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Barrett's Esophagus Makes a Difference , 2005, The American Journal of Gastroenterology.

[143]  Michael Vieth,et al.  Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.

[144]  J. Horwhat,et al.  Cryoablation of Barrett's esophagus: a pilot study. , 2005, Gastrointestinal endoscopy.

[145]  A. Ippoliti,et al.  Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[146]  D. Castell,et al.  Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease , 1999, The American Journal of Gastroenterology.

[147]  G. Chejfec,et al.  Adenocarcinomas arising in tongues or short segments of Barrett's esophagus , 2005, Digestive Diseases and Sciences.

[148]  L. Gossner,et al.  Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.

[149]  R. Kiesslich,et al.  In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[150]  Kenneth K Wang,et al.  The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus. , 2006, The Journal of molecular diagnostics : JMD.

[151]  A. Axon,et al.  Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[152]  Fumiaki Sato,et al.  CpG island hypermethylation in progression of esophageal and gastric cancer , 2006, Cancer.

[153]  P. Bampton,et al.  Improving surveillance for Barrett's oesophagus , 2006, BMJ : British Medical Journal.

[154]  A. Bansal,et al.  The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[155]  R. Sampliner,et al.  A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results , 2006, Gut.

[156]  J. Hagen,et al.  Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. , 2006, Journal of the American College of Surgeons.

[157]  A. Rastogi,et al.  Detection of Barrett's Esophagus After Endoscopic Healing of Erosive Esophagitis , 2000, The American Journal of Gastroenterology.

[158]  R. Sampliner,et al.  Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[159]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[160]  K. Yao,et al.  Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging , 2007, Alimentary pharmacology & therapeutics.

[161]  A. Csendes,et al.  Adenocarcinoma Appearing very late after antireflux surgery for barrett’s esophagus: long-term follow-up, review of the literature, and addition of six patients , 2004, Journal of Gastrointestinal Surgery.

[162]  Mari Mino-Kenudson,et al.  Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. , 2007, Gastrointestinal endoscopy.

[163]  C. Yeo,et al.  Barrett’s esophagus with high grade dysplasia: Surgical results and long-term outcome— An update , 2003, Journal of Gastrointestinal Surgery.

[164]  郷田 憲一 Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma , 2007 .

[165]  Fred S. Drennan,et al.  Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. , 2006, Gastrointestinal endoscopy.

[166]  Kenneth K Wang,et al.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.

[167]  A. Shar,et al.  Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. , 2007, Journal of the National Cancer Institute.

[168]  A. Noffsinger,et al.  Narrow band imaging directed EMR for Barrett's esophagus with high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[169]  J. Luketich,et al.  Minimally invasive resection and mechanical cervical esophagogastric anastomotic techniques in the management of esophageal cancer , 2004, Journal of Gastrointestinal Surgery.

[170]  Keith Abrams,et al.  Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies , 2007, The American Journal of Gastroenterology.

[171]  Fernando Ramos,et al.  A Randomized Comparison of Methylene Blue-Directed Biopsy Versus Conventional Four-Quadrant Biopsy for the Detection of Intestinal Metaplasia and Dysplasia in Patients With Long-Segment Barrett's Esophagus , 2008, The American Journal of Gastroenterology.